Getting started
5-(4-Bromophenyl)-46-Dichloropyrimidine CAS 146533-41-7

5-(4-Bromophenyl)-46-Dichloropyrimidine CAS 146533-41-7 - China Manufacturers, Factory, Suppliers

5-(4-Bromophenyl)-46-Dichloropyrimidine CAS 146533-41-7, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...

2022.10.18 00:58:44
2022.08.31 04:06:54
2022.03.17 05:54:08
2022.01.16 07:31:22
2021.12.19 15:24:11
2021.12.12 02:33:40

5-(4-Bromophenyl)-46-Dichloropyrimidine CAS 146533-41-7 - China Manufacturers, Factory, Suppliers

Related Products

5-(4-Bromophenyl)-4,6-Dichloropyrimidine CAS 146533-41-7 Macitentan Intermediate Purity ≥99.0% (HPLC) Factory

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Lithium Bis(fluorosulfonyl)imide (LiFSI) CAS 171611-11-3 Purity >99.9% (T) Lithium Electrolyte

2,6-Diaminopyridine CAS 141-86-6 Purity >98.0% (GC) Factory High Quality

Anastrozole CAS 120511-73-1 API Factory High Quality

Irinotecan Hydrochloride CAS 100286-90-6 Purity ≥99.0% (HPLC) API USP Standard High Purity

Piperazine Anhydrous CAS 110-85-0 Purity >99.5% (GC) Factory

4-Bromo-3,5-Dimethylpyrazole CAS 3398-16-1 Purity >99.0% (HPLC) (T)

2,5-Dimethoxybenzaldehyde CAS 93-02-7 Assay ≥98.0%

2-Bromo-6-Fluorobenzaldehyde CAS 360575-28-6 High Quality

Cytidine 5'-Monophosphate (5'-CMP) CAS 63-37-6 Purity ≥98.0% (HPLC) Factory High Purity

Fmoc-Trp(Boc)-OH CAS 143824-78-6 Purity >98.5% (HPLC) Factory

DL-Histidine CAS 4998-57-6 Assay 98.0%-101.0% (HPLC)

H-D-Phg-OEt·HCl CAS 17609-48-2 Assay ≥98.0% (HPLC)

The “Summit on COVID-19 Diagnostics & Treatment”

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Method Of Analyzing Palladium Content In Palladium Catalysts

2022.10.18 00:58:44

2022.08.31 04:06:54

2022.03.17 05:54:08

2022.01.16 07:31:22

2021.12.19 15:24:11

2021.12.12 02:33:40

related search